IGMSIGM Biosciences, Inc.


$ 12.32 $ 0.91 (7.99 %)    

Friday, 13-Sep-2024 15:59:47 EDT
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 11.48
$ 12.29 x 168
$ 12.35 x 100
$ 11.43 - $ 12.41
$ 3.81 - $ 17.70
152,554
na
675.64M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-neutral-on-igm-biosciences-lowers-price-target-to-11

HC Wainwright & Co. analyst Robert Burns maintains IGM Biosciences (NASDAQ:IGMS) with a Neutral and lowers the price tar...

 truist-securities-maintains-buy-on-igm-biosciences-lowers-price-target-to-24

Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price targe...

 wedbush-maintains-outperform-on-igm-biosciences-raises-price-target-to-25

Wedbush analyst Robert Driscoll maintains IGM Biosciences (NASDAQ:IGMS) with a Outperform and raises the price target from $...

 rbc-capital-reiterates-outperform-on-igm-biosciences-maintains-20-price-target

RBC Capital analyst Brian Abrahams reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

 jp-morgan-maintains-neutral-on-igm-biosciences-raises-price-target-to-12

JP Morgan analyst Eric Joseph maintains IGM Biosciences (NASDAQ:IGMS) with a Neutral and raises the price target from $11 to...

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 hc-wainwright--co-reiterates-neutral-on-igm-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Robert Burns reiterates IGM Biosciences (NASDAQ:IGMS) with a Neutral and maintains $12 price...

 wedbush-reiterates-outperform-on-igm-biosciences-maintains-20-price-target

Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

 igm-biosciences-q1-eps-083-inline-sales-49700k-miss-76000k-estimate

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION